{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:19:27Z","timestamp":1767176367800,"version":"build-2238731810"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National\u00a0Natural\u00a0Science\u00a0Foundation\u00a0of\u00a0China","doi-asserted-by":"crossref","award":["81702548"],"award-info":[{"award-number":["81702548"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multifaceted functions of the so-called \u201concogene\u201d Wip1 have been reported in a previous study, while its actual role remains to be explored in serous ovarian cancer (SOC). In this study, by performing bioinformatic analysis with a public database and immunohistochemical staining of Wip1 in tumour tissue from SOC, we concluded that decreased expression of Wip1 was associated with a higher rate of tumour metastasis and platinum-based therapy resistance and increased ascites volume, which led to poorer prognosis in SOC patients. We also found that overexpression of Wip1 in SKOV3 cells decreased the levels of several cytokines, including VEGF, by secretome profiling analysis, and Wip1 overexpression suppressed angiogenesis both in vitro and in vivo. Mechanistic studies indicated that overexpression of Wip1 decreased the expression of VEGF at both the protein and mRNA levels and that the inhibitory effect was mediated by dephosphorylation of STAT3 at Ser727. Our study uncovered the role of Wip1 in SOC and provides a novel therapeutic strategy for suppressing angiogenesis.<\/jats:p>","DOI":"10.1186\/s13048-022-00990-6","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T01:02:41Z","timestamp":1652144561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer"],"prefix":"10.1186","volume":"15","author":[{"given":"Sheng","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongyu","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"issue":"1","key":"990_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, et al. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"990_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2021.08.011","volume":"77","author":"C Marchetti","year":"2021","unstructured":"Marchetti C, et al. Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments. Semin Cancer Biol. 2021;77:144\u201366.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"990_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"11","key":"990_CR4","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.4161\/cc.9.11.11810","volume":"9","author":"SH Moon","year":"2010","unstructured":"Moon SH, et al. Dephosphorylation of gamma-H2AX by WIP1: an important homeostatic regulatory event in DNA repair and cell cycle control. Cell Cycle. 2010;9(11):2092\u20136.","journal-title":"Cell Cycle"},{"issue":"5","key":"990_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.molcel.2006.07.010","volume":"23","author":"S Shreeram","year":"2006","unstructured":"Shreeram S, et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol Cell. 2006;23(5):757\u201364.","journal-title":"Mol Cell"},{"issue":"2","key":"990_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ng894","volume":"31","author":"DV Bulavin","year":"2002","unstructured":"Bulavin DV, et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet. 2002;31(2):210\u20135.","journal-title":"Nat Genet"},{"issue":"2","key":"990_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng888","volume":"31","author":"J Li","year":"2002","unstructured":"Li J, et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat Genet. 2002;31(2):133\u20134.","journal-title":"Nat Genet"},{"issue":"9","key":"990_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1440-1827.2007.02140.x","volume":"57","author":"T Fuku","year":"2007","unstructured":"Fuku T, et al. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma. Pathol Int. 2007;57(9):566\u201371.","journal-title":"Pathol Int"},{"issue":"5","key":"990_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1349-7006.2011.01898.x","volume":"102","author":"N Satoh","year":"2011","unstructured":"Satoh N, et al. Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival. Cancer Sci. 2011;102(5):1101\u20136.","journal-title":"Cancer Sci"},{"issue":"7353","key":"990_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Integrated genomic analyses of ovarian carcinoma","year":"2011","unstructured":"Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609\u201315.","journal-title":"Nature"},{"issue":"20","key":"990_CR11","doi-asserted-by":"publisher","first-page":"29359","DOI":"10.18632\/oncotarget.8833","volume":"7","author":"S Yin","year":"2016","unstructured":"Yin S, et al. Wip1 suppresses ovarian cancer metastasis through the ATM\/AKT\/Snail mediated signaling. Oncotarget. 2016;7(20):29359\u201370.","journal-title":"Oncotarget"},{"issue":"2","key":"990_CR12","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1073\/pnas.1107017108","volume":"109","author":"AR Goloudina","year":"2012","unstructured":"Goloudina AR, et al. Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents. Proc Natl Acad Sci U S A. 2012;109(2):E68-75.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"990_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1182\/blood-2012-05-432674","volume":"121","author":"G Liu","year":"2013","unstructured":"Liu G, et al. Phosphatase Wip1 negatively regulates neutrophil development through p38 MAPK-STAT1. Blood. 2013;121(3):519\u201329.","journal-title":"Blood"},{"issue":"7432","key":"990_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature11725","volume":"493","author":"E Ruark","year":"2013","unstructured":"Ruark E, et al. Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature. 2013;493(7432):406\u201310.","journal-title":"Nature"},{"issue":"9","key":"990_CR15","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.18632\/oncotarget.3118","volume":"6","author":"Z Wang","year":"2015","unstructured":"Wang Z, et al. Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis. Oncotarget. 2015;6(9):6670\u201383.","journal-title":"Oncotarget"},{"issue":"10","key":"990_CR16","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.4161\/cc.19901","volume":"11","author":"AR Goloudina","year":"2012","unstructured":"Goloudina AR, et al. Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax\/Bcl-xL ratio. Cell Cycle. 2012;11(10):1883\u20137.","journal-title":"Cell Cycle"},{"key":"990_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.96","volume":"7","author":"V Clausse","year":"2016","unstructured":"Clausse V, et al. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy. Cell Death Dis. 2016;7: e2195.","journal-title":"Cell Death Dis"},{"key":"990_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.750022","volume":"9","author":"A Vuletic","year":"2021","unstructured":"Vuletic A, et al. Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer. Front Cell Dev Biol. 2021;9: 750022.","journal-title":"Front Cell Dev Biol"},{"key":"990_CR19","doi-asserted-by":"publisher","first-page":"9918379","DOI":"10.1155\/2021\/9918379","volume":"2021","author":"I Chattopadhyay","year":"2021","unstructured":"Chattopadhyay I, Ambati R, Gundamaraju R. Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer. Mediators Inflamm. 2021;2021:9918379.","journal-title":"Mediators Inflamm"},{"issue":"5","key":"990_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ncb1873","volume":"11","author":"J Chew","year":"2009","unstructured":"Chew J, et al. WIP1 phosphatase is a negative regulator of NF-kappaB signalling. Nat Cell Biol. 2009;11(5):659\u201366.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"990_CR21","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.4049\/jimmunol.1300656","volume":"192","author":"B Sun","year":"2014","unstructured":"Sun B, et al. Phosphatase Wip1 negatively regulates neutrophil migration and inflammation. J Immunol. 2014;192(3):1184\u201395.","journal-title":"J Immunol"},{"key":"990_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cellimm.2016.07.012","volume":"310","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, et al. Wip 1 inhibits intestinal inflammation in inflammatory bowel disease. Cell Immunol. 2016;310:63\u201370.","journal-title":"Cell Immunol"},{"key":"990_CR23","doi-asserted-by":"publisher","first-page":"17018","DOI":"10.1038\/cddiscovery.2017.18","volume":"3","author":"B Uyanik","year":"2017","unstructured":"Uyanik B, et al. DNA damage-induced phosphatase Wip1 in regulation of hematopoiesis, immune system and inflammation. Cell Death Discov. 2017;3:17018.","journal-title":"Cell Death Discov"}],"updated-by":[{"DOI":"10.1186\/s13048-022-01017-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T00:00:00Z","timestamp":1657411200000}}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-00990-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-022-00990-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-00990-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T18:31:55Z","timestamp":1657650715000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-022-00990-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["990"],"URL":"https:\/\/doi.org\/10.1186\/s13048-022-00990-6","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"12 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13048-022-01017-w","URL":"https:\/\/doi.org\/10.1186\/s13048-022-01017-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}